octreotide pamoate

Known as: OP LAR, Octreotide Embpnate, Octreotide Pamoate LAR(SMS 201-995) 
A synthetic long-acting octapeptide analogue of endogenous somatostatin. Octreotide pamoate binds to somatostatin receptors expressed by some… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2010
01219982010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Known agonists of the orphan receptor GPR35 are kynurenic acid, zaprinast, 5-nitro-2-(3-phenylproplyamino) benzoic acid, and… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
The insulin-like growth factor (IGF)-system was evaluated in 150 breast cancer patients participating in a randomised phase III… (More)
Is this relevant?
2004
2004
OBJECTIVE High-dose somatostatin analogue treatment has shown an antiproliferative effect in one study including patients with… (More)
Is this relevant?
2002
2002
BACKGROUND Long-acting release octreotide pamoate (OP-LAR) is a synthetic octapeptide that can be administered monthly and whose… (More)
Is this relevant?
2002
2002
PURPOSE The purpose of this research was to determine whether insulin-like growth factor (IGF) suppression, using a long-acting… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
1998
1998
Fourteen patients suffering from advanced colorectal (n = 7), pancreatic (n = 4) or gastric (n = 3) carcinomas received treatment… (More)
  • table 1
  • table 2
Is this relevant?